About Amicus Formulations India Private Limited
Data last updated:
Amicus Formulations India Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 28 November 2014 and has been in existence for over 12 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24232TG2014PTC096589.
The company has an authorised share capital of ₹8 Cr and a paid-up capital of ₹7.76 Cr. It is led by directors Vamshider Joganpally Rao and Sushanth Yellapantula.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at H No:8 – 2 – 686/6/D/5 Road No:12 Banjara Hills, Hyderabad, Telangana, India – 500034.
The company has 29 deals on record (23 rights issues, 4 secondary share transfers, 2 funding rounds), with disclosed funding of ₹5.1 Cr; the latest was in February 2019.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website genesysbiologics.com.
- EmailLocked
- TelephoneLocked
- Website
- Social Media
- Registered AddressH No:8 – 2 – 686/6/D/5 Road No:12 Banjara Hills, Hyderabad, Telangana, India – 500034
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Amicus Formulations India Private Limited
The main business activity of Amicus Formulations India is professional, scientific and technical. In detail, this covers other professional, scientific and technical activities.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| M | Professional, Scientific and Technical | M9 | Other professional, scientific and technical activities | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Amicus Formulations India Private Limited FY 2024 filings available
Amicus Formulations India Private Limited reported revenue of ₹1,200 (down 96% YoY) for FY 2023.
Compounded Annual Growth Rate (CAGR) of Amicus Formulations India Private Limited
Revenue has declined at a compounded annual rate (CAGR) of 74% over five years, including a 96% fall in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Amicus Formulations India Private Limited
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | ₹1,200 | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | •••• | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | •••• | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Amicus Formulations India Private Limited
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | •••• | •••• | •••• | •••• | •••• |
| Net Profit Margin | •••• | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Amicus Formulations India are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Auditor Details of Amicus Formulations India Private Limited
Amicus Formulations India Private Limited is audited by Anant Rao & Mallik for the financial year 2023.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| Anant Rao & Mallik | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Amicus Formulations India Private Limited
Amicus Formulations India has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sushanth Yellapantula Also directs: Fonte Advisory LLP | Additional Director | 16 Apr 2024 | 2 Years 5 Months | Current |
| Vamshider Joganpally Rao | Director | 28 Nov 2014 | 11 Years 10 Months | Current |
Ownership and Shareholding of Amicus Formulations India Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Amicus Formulations India Private Limited
Amicus Formulations India Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Deals & Funding of Amicus Formulations India Private Limited
Amicus Formulations India Private Limited has 29 deals on record (23 rights issues, 4 secondary share transfers, 2 funding rounds), with disclosed funding of ₹5.1 Cr; the latest was in February 2019.
Deals on record (5 of 29)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Feb 2019 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: an individual |
| Oct 2018 | Secondary share transfer | Undisclosed | Buyer: 3 individuals Seller: an individual |
| Sep 2017 | Rights issue | ₹4.92 Cr | Investors: 4 individuals Seller: 4 individuals |
| Jul 2017 | Rights issue | ₹1.14 Cr | Investors: 3 individuals |
| Jun 2017 | Rights issue | ₹37 Lakh | Investors: an individual |
Full deal history
All 29 deals with amounts, valuations, instruments and every party are in the company report.
- Every funding round and share transfer
- Amounts and valuations
- Investors, buyers and sellers
- Instruments and deal dates
Verified entity values are shown only after access is granted.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Employees and EPFO Compliance at Amicus Formulations India Private Limited
Employment history and EPFO contributions of people linked to Amicus Formulations India.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Group Structure of Amicus Formulations India Private Limited
Amicus Formulations India has 1 associated company. This group structure data is as of FY 2023. The table lists each entity with its relationship and holding.
Recent Activity on Amicus Formulations India Private Limited
Amicus Formulations India Private Limited has 4 board changes on record since 2014: 2 appointments and 2 cessations. The latest: Krishna Yeachuri ceased to be Director on 17 Apr 2024.
Credit Ratings, Litigation & Regulatory Alerts for Amicus Formulations India Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Amicus Formulations India Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Amicus Formulations India Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Amicus Formulations India Private Limited
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Amicus Formulations India Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Amicus Formulations India Private Limited
Amicus Formulations India is an active private limited company based in Hyderabad, Telangana, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 28 November 2014 (12+ years old) and is registered under CIN U24232TG2014PTC096589.
Amicus Formulations India has 2 current directors:
- Sushanth Yellapantula - Additional Director
- Vamshider Joganpally Rao - Director
The CIN (Corporate Identification Number) of Amicus Formulations India is U24232TG2014PTC096589. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Amicus Formulations India was incorporated on 28 November 2014, making it 12+ years old. It is registered with the Registrar of Companies, Hyderabad.
Amicus Formulations India has 29 deals on record (23 rights issues, 4 secondary share transfers, 2 funding rounds), with disclosed funding of ₹5.1 Cr; the latest was in February 2019.
Krishna Yeachuri ceased to be Director on 17 Apr 2024. Sushanth Yellapantula was appointed as Additional Director on 16 Apr 2024. Rajender Juvvadi Rao ceased to be Director on 20 Nov 2020. Amicus Formulations India has 4 board changes on record in total.
Amicus Formulations India can be reached through the website genesysbiologics.com. Its registered office is in Hyderabad, Telangana, India.
The registered office of Amicus Formulations India is at H No:8 – 2 – 6866D5 Road No:12 Banjara Hills, Hyderabad, Telangana, India – 500034.
Amicus Formulations India has an authorised share capital of ₹8 Cr and a paid-up capital of ₹7.76 Cr.
Amicus Formulations India operates in the pharma industry, in the drug formulation and development segment.